BioIntelliSense, a medical-grade on-body sensor for scalable remote care, raised $12 million, according to its filings.
Early this year, the company received FDA clearance for its on-body wearable sensor device (BioSticker). According to the company, the on-body sensor device is designed to be worn on the upper left chest for effortless remote data capture, monitor vital signs, and deliver actionable insights to clinicians.
The physician prescribed wearable device is for up to 30 days of continuous health monitoring, and it monitors respiratory rate, heart rate at rest, skin temperature, body position, activity levels, sleep status, sneezing frequency, coughing frequency, vomiting frequency, and fall & symptomatic events, according to the company. The wearable device is connected to an analytics platform, enabling clinicians to access high-resolution patient trending and reporting to allow medical-grade care in the home.
BioIntelliSense has also partnered with UCHealth and its CARE Innovation Center to develop and validate new data-driven care models that are patient-centered and built for scale.
“The BioSticker device for continuous health monitoring enables us to monitor a patient in their home and recognize when a patient may worsen illness even before they manifest symptoms. This may reduce hospitalizations, emergency department visits, and shorten hospital stays, creating cost efficiencies for health systems,” said Dr. Richard Zane, UCHealth Chief Innovation Officer.
More recently, the company introduced the BioButton device, a coin-sized, disposable medical device that measures continuous temperature and other vital signs for up to 90-days, according to the company.
Wearable Sensors companies raised $321 million in the first half of 2020. Recently, Element Science, a provider of patch-based wearable cardioverter defibrillator that monitors a patient’s heart, raised $145.6 million. Hinge Health, a developer of wearable bands with motion sensors that help employees recuperate from musculoskeletal problems such as the lower back, knee, shoulder, and neck pain, raised $90 million.
Image Credit: BioIntelliSense
